Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma

AACR 2009

18 - 22 Apr 2009

Published: 1 May 2009

Views: 17579

Rating:

Save

Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania

Donald M. O’Rourke, M.D., associate professor of neurosurgery, University of Pennsylvania, at AACR 2009 Denver: Identification of the EGFRvIII Mutation in Glioblastoma by Magnetic Resonance Perfusion-Weighted Imaging (MR-PWI) and VEGF Expression

Related Videos

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis

Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis )

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )

Tomosynthesis guided biopsy

Prof Shilpa Lad - NM Medical Centre, Mumbai, India

Tomosynthesis guided biopsy ( Prof Shilpa Lad - NM Medical Centre, Mumbai, India )

Evidence-based approach to lymph node assessment and targeted axillary dissection

Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA

Evidence-based approach to lymph node assessment and targeted axillary dissection ( Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA )

More from ecancer